Through
4/26
The new technology for cellular immunotherapy shows promising anti-tumor activity in the lab against hard-to-treat cancers driven the KRAS mutation.
Penn researchers are looking to mRNA vaccines for applications outside of infectious diseases, as they can not only prompt strong antibody responses to fight off invaders, like COVID-19, but also potent cytotoxic T cell responses.
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, but the takeaway is not to change testing guidelines based on race alone, but focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
Penn scientists have developed a new method for tracing the lineage and gene expression patterns of metastatic cancer at the single-cell level.
An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95% accuracy.
Richard Phillips, a Presidential Assistant Professor of Neurology and member of the Penn Epigenetics Institute, hopes to bring glioma research out of the “basement.”
Afive-year community outreach and engagement effort more than doubled the percentage of participants, improving access and treatment for a group with historically low representation in cancer research.
With the disruption of cancer care since the pandemic began in March 2020, recent reports are starting to show that the interruption—while still significant—may not be as detrimental as experts originally feared.
Penn scientists use cryo-electron microscopy to illuminate how a chemical compound found in the plant, piperlongumine, works against glioblastoma.
The new members of the Academy, honored scholars recognized for their unique and ongoing contributions to original research, include researchers from the Perelman School of Medicine, School of Engineering and Applied Science, and Annenberg School for Communication.
A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.
FULL STORY →
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
Penn Medicine researchers like Nobel laureate Drew Weissman are leading efforts to develop a vaccine that prevents cancer, with remarks from Susan Domchek of the Basser Center for BRCA and Robert H. Vonderheide of the Abramson Cancer Center.
FULL STORY →
A trial led by Susan Domchek of the Perelman School of Medicine could use a preventive vaccine to protect people with a BRCA gene mutation from cancer.
FULL STORY →
Daiwei Zhang and Mingyao Li of the Perelman School of Medicine and colleagues have developed an AI tool called iStar that can automatically spot tumors and types of cancer that are difficult for clinicians to see or identify and can predict candidates for immunotherapy.
FULL STORY →
The Abramson Cancer Center is attempting to address one of the most common challenges cancer patients face: lack of transportation to critically important appointments. Robert Vonderheide and Carmen Guerra of the Perelman School of Medicine are quoted on the Ride Health initiative.
FULL STORY →